Author name: PRNewswire

Atossa1 Logo

Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinical Program in ER+/HER2- Metastatic Breast Cancer

SEATTLE, July 29, 2025 /PRNewswire/ — Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced positive written feedback from the U.S. Food and Drug Administration (FDA) regarding the company’s proposed dose optimization trial of (Z)-endoxifen for the treatment of estrogen receptor positive (ER+), human epidermal growth factor receptor […]

Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinical Program in ER+/HER2- Metastatic Breast Cancer Read Post »

Press
Jacobs Logo

Jacobs to Continue Supporting Denver International Airport Transformation

Rental car facility will support passenger growth and improved airport experience DALLAS, July 29, 2025 /PRNewswire/ — Jacobs (NYSE: J) was selected to provide program management support services for the Consolidated Rent-A-Car Facility (ConRAC) and Common Transportation System (CTS) at Denver International Airport (DEN). This project is a critical component of the airport’s ambitious capital

Jacobs to Continue Supporting Denver International Airport Transformation Read Post »

Press
commvault new logo

Commvault Announces First Quarter Fiscal 2026 Financial Results

Exceeded Guidance Across All Top Line Metrics Record Total Revenue of $282 million, up 26% year-over-year Annualized Recurring Revenue (ARR)1 grew to $996 million, up 24% year-over- year TINTON FALLS, N.J., July 29, 2025 /PRNewswire/ — Commvault [Nasdaq: CVLT] today announced its financial results for the fiscal first quarter ended June 30, 2025.  “Commvault delivered a strong

Commvault Announces First Quarter Fiscal 2026 Financial Results Read Post »

Press
Govee Launches Industry First All Around Dynamic Outdoor Wall Light

Govee Launches Industry-First All-Around Dynamic Outdoor Wall Light

SEATTLE, July 29, 2025 /PRNewswire/ — Govee, a global leader in smart lighting innovation, today announces the launch of theGovee Outdoor UpDown Wall Light, the industry’s first all-around dynamic wall light featuring independently adjustable colors on all four sides. Built for those seeking immersive ambiance and advanced smart features, this fixture brings a vibrant, customizable glow

Govee Launches Industry-First All-Around Dynamic Outdoor Wall Light Read Post »

Press
Alzheimers Association Logo

LA CONFERENCIA INTERNACIONAL DE LA ASOCIACIÓN DE ALZHEIMER 2025 REVELA LOS HALLAZGOS DEL ESTUDIO U.S. POINTER

-DE LA CONFERENCIA INTERNACIONAL DE LA ASOCIACIÓN DE ALZHEIMER 2025: UN ESTUDIO U.S. POINTER MUESTRA QUE UN PROGRAMA DE ESTILO DE VIDA ESTRUCTURADO DIRIGIDO A VARIOS FACTORES DE RIESGO MEJORA LA COGNICIÓN EN ADULTOS MAYORES CON RIESGO DE DETERIORO COGNITIVO Conclusiones clave Dos intervenciones de estilo de vida en el programa U.S. POINTER mejoraron la cognición

LA CONFERENCIA INTERNACIONAL DE LA ASOCIACIÓN DE ALZHEIMER 2025 REVELA LOS HALLAZGOS DEL ESTUDIO U.S. POINTER Read Post »

Press
Starlab and Journey Logo

Journey Joins Starlab to Design the Commercial Space Station Experience

HOUSTON, July 29, 2025 /PRNewswire/ — Starlab Space LLC announced a strategic partnership with Journey, a multidimensional experience agency, that will help shape the interior and experiential design of the next-generation commercial space station. Journey joins Hilton and Airbus in developing a station environment that elevates how astronauts live and work in orbit. Journey brings

Journey Joins Starlab to Design the Commercial Space Station Experience Read Post »

Press

Trevi Therapeutics to Participate in Upcoming August Conferences

NEW HAVEN, Conn., July 29, 2025 /PRNewswire/ — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER)  for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC), today announced that senior management will be participating

Trevi Therapeutics to Participate in Upcoming August Conferences Read Post »

Press
ARTBIO Logo Logo

ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure

Financing co-led by new investors Sofinnova Investments and B Capital, along with an existing investor with continued support from F-Prime, Omega Funds, and Third Rock Ventures. Additional new investors include Qatar Investment Authority and Alexandria Venture Investments. Funding will support the advancement of lead asset AB001 through Phase II development, the progress of additional undisclosed

ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure Read Post »

Press
Scroll to Top